3-n-methylspiperone has been researched along with ketamine in 4 studies
| Studies (3-n-methylspiperone) | Trials (3-n-methylspiperone) | Recent Studies (post-2010) (3-n-methylspiperone) | Studies (ketamine) | Trials (ketamine) | Recent Studies (post-2010) (ketamine) |
|---|---|---|---|---|---|
| 155 | 6 | 7 | 15,029 | 2,321 | 6,678 |
| Protein | Taxonomy | 3-n-methylspiperone (IC50) | ketamine (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 4.216 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 4.216 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 5.02 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 5.02 | |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 3.7762 | |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 3.5563 | |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 4.1059 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 5.02 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 5.02 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 5.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, O; Itoh, T; Suhara, T; Tsukada, H; Yamasaki, T; Yonezawa, H | 1 |
| Inoue, O; Itoh, T; Mataga, N; Onoe, H; Suzuki, K; Tsukada, H; Watanabe, Y | 1 |
| Inoue, O; Kobayashi, K; Långström, B; Onoe, H; Watanabe, Y | 1 |
| Conley, RR; Tamminga, CA | 1 |
1 review(s) available for 3-n-methylspiperone and ketamine
| Article | Year |
|---|---|
The application of neuroimaging techniques to drug development.
Topics: Antipsychotic Agents; Brain; Brain Chemistry; Carbon Radioisotopes; Cerebrovascular Circulation; Deoxyglucose; Diagnostic Imaging; Drug Industry; Drugs, Investigational; Fluorodeoxyglucose F18; Haloperidol; Humans; Ketamine; Magnetic Resonance Imaging; Mental Disorders; Neuropharmacology; Receptors, Dopamine; Spiperone; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1997 |
3 other study(ies) available for 3-n-methylspiperone and ketamine
| Article | Year |
|---|---|
Effect of lithium and anesthetics on in vivo binding of dopamine receptors.
Topics: Animals; Apomorphine; Benzazepines; Ketamine; Lithium; Male; Mice; Mice, Inbred C3H; Pentobarbital; Rats; Receptors, Dopamine; Spiperone | 1991 |
Ketamine increases the striatal N-[11C]methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey.
Topics: Animals; Behavior, Animal; Carbon Radioisotopes; Corpus Striatum; Dopamine; Ketamine; Macaca mulatta; Male; Microdialysis; Radioligand Assay; Spiperone; Tomography, Emission-Computed | 1994 |
Difference in response of D2 receptor binding between 11C-N-methylspiperone and 11C-raclopride against anesthetics in rhesus monkey brain.
Topics: Anesthetics; Animals; Brain; Carbon Radioisotopes; Dopamine Agonists; Dopamine Antagonists; Female; Isoflurane; Ketamine; Macaca mulatta; Raclopride; Receptors, Dopamine D2; Salicylamides; Spiperone; Tomography, Emission-Computed | 1995 |